全部

1·Insulin Glargine does not treat postprandial hyperglycemia.

甘精胰岛素不能治疗餐后高血糖。

2·Can you give us your perspective on the relationship between insulin glargine and cancer risk?

您能就甘精胰岛素和癌症风险之间的关系说一下您的观点吗？

3·Objective To investigate the protective effect of insulin glargine in myocardium of diabetic rats.

目的 探讨甘精胰岛素对糖尿病大鼠心肌的保护作用。

4·Similar to human insulin, insulin glargine is used to control blood sugar in people with Type 1 and Type 2 diabetes.

甘精胰岛素和人体胰岛素相似，用于1型和2型糖尿病患者的血糖控制。

5·Objective To investigate the feasibility of perioperative glycemic control with insulin glargine in type 2 diabetic patients.

目的探讨使用甘精胰岛素进行2型糖尿病患者围手术期血糖控制的可行性。

6·Insulin glargine is an insulin analogue which has better glucose control and less hypoglycemic episodes, but has higher price.

甘精胰岛素是胰岛素的类似物，可以使患者在获得较好血糖控制的同时较少发生低血糖反应，但其价格相对较高。

7·Clearly it's a signal that there may be something going on here with breast cancer in the long-term users of insulin glargine.

显然，它是一个信号，在甘精胰岛素长期使用者中可能有关于乳腺癌的某种事情正在进行。

8·Conclusions Insulin Glargine intensification therapy can control high blood sugar well and the incidence of hypoglycemia is low.

结论甘精胰岛素强化治疗可以良好地控制高血糖，且低血糖发生率低。

9·Insulin Glargine is effective in hospitalized and postsurgical patients on account of its lack of pronounced insulin peaks and long duration of action.

对于明显缺乏胰岛素峰值和长期应用的住院治疗及手术后患者使用甘精胰岛素是有效果的。

10·Such a therapy may be less costly, but the major advantage of insulin Glargine remains the greater safety of a lower frequency of hypoglycemic reactions.

这种疗法的成本可能较低，但甘精胰岛素的主要优点是低血糖反应有较低的发生率，使其具有更大的安全性。